Fludarabina - Utilidade terapêutica

Authors

  • João F. Sequeira Serviço de Medicina I (Dir: Prof.Nogueira da Costa)

Keywords:

.

Downloads

Download data is not yet available.

References

Tefferi A, Phyliky R L. A clinical update on chronic lymphocytic leukemia. Critical analysis of current chemotherapeutic mo­phocytic leukemia Proceedings of the American Society of He­matology; Blood 1986; 68: 223a

Han T, Rai K R. Management of chronic lymphocytic leukemia Hematology/Oncology Clinics of North America 1990; 4 (2):

-445

Kantarjian H M, et al. Fludarabine therapy in macroglobulinemic Iymphoma. Blood 1990; 75: 1928-1931

Grever M R, et al. Fludarabine monophosphate in chronic lym-

Keating MJ, et al. Fludarabine: A new agent with major activity against chronic lymphocytic leukemia. Blood 1989; 74: 19-25

Robertson L E, et al. Response assessment in chronic Iymphocy­tic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic and molecular analysis. Blood 1992; 80: 29-36

Additional Files

Published

1994-03-31

How to Cite

1.
Sequeira JF. Fludarabina - Utilidade terapêutica. RPMI [Internet]. 1994 Mar. 31 [cited 2024 Nov. 23];1(1):70-. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/2442

Issue

Vol. 1 No. 1 (1994): Janeiro/ Março

Section

Letters to Editor

License

Copyright (c) 1994 Internal Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Medicina Interna

Open Access

Most read articles by the same author(s)